Landmark Malaria Vaccine Pilot Launches In Malawi
Executive Summary
The first ever malaria vaccine is being launched in three African countries in an effort to gather more evidence about how it should be used in real life settings.
You may also be interested in...
Fresh Funds For Trials Of Novartis’s Novel Malaria Combo In Africa
New funding has been provided for more trials of Novartis’s combination malaria treatment in west and central Africa, adding to ongoing efforts to tackle the disease on the continent.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.